Jamison Private Wealth Management, Inc. Gilead Sciences, Inc. Transaction History
Jamison Private Wealth Management, Inc.
- $677 Billion
- Q4 2024
A detailed history of Jamison Private Wealth Management, Inc. transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Jamison Private Wealth Management, Inc. holds 27,957 shares of GILD stock, worth $3.09 Million. This represents 0.38% of its overall portfolio holdings.
Number of Shares
27,957
Previous 26,436
5.75%
Holding current value
$3.09 Million
Previous $2.22 Billion
16.51%
% of portfolio
0.38%
Previous 0.34%
Shares
6 transactions
Others Institutions Holding GILD
# of Institutions
2,091Shares Held
1.02BCall Options Held
8.73MPut Options Held
9.63M-
Black Rock Inc. New York, NY121MShares$13.3 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA116MShares$12.8 Billion0.19% of portfolio
-
Capital World Investors Los Angeles, CA71.7MShares$7.92 Billion1.05% of portfolio
-
State Street Corp Boston, MA60.4MShares$6.67 Billion0.23% of portfolio
-
Capital Research Global Investors Los Angeles, CA57.9MShares$6.4 Billion1.15% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $138B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...